: Moderna COVID-19 vaccine rollout begins in England, giving under 30s alternative to AstraZeneca
The Moderna MRNA, -1.08% 0A45, -2.63% COVID-19 vaccine will start to be used in England from Tuesday, providing an alternative to the AstraZeneca AZN, -1.04% AZN, -0.98% vaccine for people aged under 30. The U.K.’s vaccine advisory committee, the Joint Committee on Vaccination and Immunisation (JCVI), last week recommended that 18 to 29-year-olds be given a […]
Continue Reading